Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.
Humanitas Clinical Research Institute, Arrhythmia and Electrophysiology Unit II, Rozzano, Milan, Italy.
Eur Radiol. 2018 Jun;28(6):2406-2416. doi: 10.1007/s00330-017-5098-z. Epub 2018 Jan 9.
To investigate safety and diagnostic value of 1.5-T MRI in carriers of conventional pacemaker (cPM) or conventional implantable defibrillator (cICD).
We prospectively compared cPM/cICD-carriers undergoing MRI (study group, SG), excluding those device-dependent or implanted <6 weeks before enrolment or prior to 01/01/2000, with cPM/cICD-carriers undergoing chest x-ray, CT or follow-up (reference group, RG).
142 MRI (55 cardiac) were performed in 120 patients with cPM (n=71) or cICD (n=71). In the RG 98 measurements were performed in 95 patients with cPM (n=40) or cICD (n=58). No adverse events were observed. No MRI prolonged/interrupted. All cPM/cICD were correctly reprogrammed after MRI without malfunctions. One temporary communication failure was observed in one cPM-carrier. Immediately after MRI, 12/14 device interrogation parameters did not change significantly (clinically negligible changes of battery voltage and cICD charging time), without significant variations for SG versus RG. Three-12 months after MRI, 9/11 device interrogation parameters did not change significantly (clinically negligible changes of battery impedance/voltage). Non-significant changes of three markers of myocardial necrosis. Non-cardiac MRI: 82/87 diagnostic without artefacts; 4/87 diagnostic with artefacts; 1/87 partially diagnostic. Cardiac MRI: in cPM-carriers, 14/15 diagnostic with artefacts, 1/15 partially diagnostic; in cICD-carriers, 9/40 diagnostic with artefacts, 22 partially diagnostic, nine non-diagnostic.
A favourable risk-benefit ratio of 1.5-T MRI in cPM/cICD carriers was reported.
• Cooperation between radiologists and cardiac electrophysiologists allowed safe 1.5-T MRI in cPM/cICD-carriers. • No adverse events for 142 MRI in 71 cPM-carriers and 71 cICD-carriers. • Ninety-nine per cent (86/87) of non-cardiac MRI in cPM/cICD-carriers were diagnostic. • All cPM-carrier cardiac MRIs had artefacts, 14 examinations diagnostic, 1 partially diagnostic. • Twenty-three per cent (9/40) of cardiac MRI in cICD-carriers were non-diagnostic.
研究 1.5T MRI 对传统起搏器(cPM)或传统植入式除颤器(cICD)携带者的安全性和诊断价值。
我们前瞻性比较了接受 MRI(研究组,SG)的 cPM/cICD 携带者,排除了设备依赖或植入 <6 周前或 2000 年 1 月 1 日前的携带者,以及接受胸部 X 线、CT 或随访的 cPM/cICD 携带者(对照组,RG)。
在 120 例接受 cPM(n=71)或 cICD(n=71)的患者中进行了 142 次 MRI(55 次心脏)。在 RG 中,95 例接受 cPM(n=40)或 cICD(n=58)的患者进行了 98 次测量。未观察到不良事件。没有 MRI 延长/中断。所有 cPM/cICD 在 MRI 后均正确重新编程,无故障。在 1 例 cPM 携带者中观察到 1 次临时通讯故障。MRI 后立即,12/14 个设备检测参数无明显变化(电池电压和 cICD 充电时间的临床可忽略变化),SG 与 RG 之间无显著差异。MRI 后 3-12 个月,9/11 个设备检测参数无明显变化(电池阻抗/电压的临床可忽略变化)。心肌坏死的三个标志物无明显变化。非心脏 MRI:82/87 次无伪影诊断;4/87 次有伪影诊断;1/87 次部分诊断。心脏 MRI:在 cPM 携带者中,14/15 次有伪影诊断,1/15 次部分诊断;在 cICD 携带者中,9/40 次有伪影诊断,22 次部分诊断,9 次非诊断。
报告了 1.5T MRI 在 cPM/cICD 携带者中的有利风险效益比。
放射科医生和心脏电生理学家之间的合作允许对 cPM/cICD 携带者进行安全的 1.5T MRI。
在 71 例 cPM 携带者和 71 例 cICD 携带者中,142 次 MRI 无不良事件。
99%(86/87)的 cPM/cICD 携带者的非心脏 MRI 可诊断。
所有 cPM 携带者的心脏 MRI 均有伪影,14 次检查可诊断,1 次部分诊断。
cICD 携带者中有 23%(9/40)的心脏 MRI 不可诊断。